Get the Stockscreener App
80.98
1.85%
1.4095
Healthequity Inc stock is traded at $80.98, with a volume of 140.21K.
It is up +1.85% in the last 24 hours and up +2.74% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$79.57
Open:
$79.91
24h Volume:
140.21K
Relative Volume:
0.15
Market Cap:
$6.88B
Revenue:
$1.29B
Net Income/Loss:
$191.83M
P/E Ratio:
37.11
EPS:
2.182
Net Cash Flow:
$362.67M
1W Performance:
+5.54%
1M Performance:
+2.74%
6M Performance:
-13.54%
1Y Performance:
-3.88%
1-Day Range:
$79.86
$82.10
1-Week Range:
$75.31
$83.36
52-Week Range:
$72.76
$116.65
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, TEM, BTSG, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQY
Healthequity Inc
|
80.54 | 6.80B | 1.29B | 191.83M | 362.67M | 2.182 |
|
VEEV
Veeva Systems Inc
|
186.19 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.36 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.76 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
WAY
Waystar Holding Corp
|
24.82 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Deutsche Bank Adjusts HealthEquity Price Target to $128 From $120, Maintains Buy Rating - marketscreener.com
BMO Maintains Market Perform on HealthEquity (HQY) March 18, 2026 - Meyka
HealthEquity analysts cut their forecasts after Q4 results - MSN
HealthEquity Inc. Earnings Call Highlights Profitable Growth - TipRanks
Reasons to hold HealthEquity stock in your portfolio for now - MSN
HealthEquity (HQY) Margin Expansion To 16.4% Tests Bearish Cost Narratives - simplywall.st
HealthEquity Q4 Earnings Call Highlights - Yahoo Finance
New health sharing program has seen 236% growth rate, with high hopes for 2026 - AOL.com
HealthEquity (HQY): Analyst Lowers Price Target Amid Maintained Rating | HQY Stock News - GuruFocus
JP Morgan Maintains Rating, Lowers Price Target for HealthEquity (HQY) | HQY Stock News - GuruFocus
HealthEquity stock price target lowered to $100 by RBC on yield outlook By Investing.com - Investing.com India
JPMorgan Chase & Co. Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat
HealthEquity (NASDAQ:HQY) Given New $110.00 Price Target at Barrington Research - MarketBeat
HealthEquity Analysts Cut Their Forecasts After Q4 Results - Benzinga
HQY: RBC Capital Maintains Outperform Rating, Lowers Price Targe - GuruFocus
HealthEquity, Inc. 2026 Annual Report: Technology-Driven HSA Solutions, Competitive Strategy, AI Innovation, and Risk Factors 232527293940 - Minichart
HealthEquity stock price target lowered to $100 by RBC on yield outlook - Investing.com Canada
BMO reiterates HealthEquity stock rating on strong quarter, AI progress By Investing.com - Investing.com India
Royal Bank Of Canada Has Lowered Expectations for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat
BMO reiterates HealthEquity stock rating on strong quarter, AI progress - Investing.com
HealthEquity (HQY) Q4 EPS Plunges 42.6% YoY to $0.95, Misses Estimates Despite $334.6M Revenue Beat - AlphaStreet
RBC Cuts Price Target on HealthEquity to $100 From $110, Keeps Outperform Rating - marketscreener.com
Faithward Advisors Boosts HealthEquity Stake to $4.41 Million - National Today
Faithward Advisors LLC Takes $4.41 Million Position in HealthEquity, Inc. $HQY - MarketBeat
HQY SEC FilingsHealthequity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Crown Advisors Management Inc. Invests $1.90 Million in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade) - Seeking Alpha
Healthequity Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia
Decoding HealthEquity Inc (HQY): A Strategic SWOT Insight - GuruFocus
HealthEquity Inc (HQY) Q4 2026 Earnings Call Highlights: Record HSA Growth and Strong Financial ... By GuruFocus - Investing.com Canada
HealthEquity Inc (HQY) Q4 2026 Earnings Call Highlights: Record HSA Growth and Strong Financial Performance - GuruFocus
HealthEquity (HQY) Fourth Quarter 2026 Earnings Call Transcript - Bitget
HealthEquity (NASDAQ:HQY) Issues Quarterly Earnings Results - MarketBeat
HealthEquity 2026 Earnings Report: Q4 and Full Year ResultsNews and Statistics - IndexBox
HealthEquity (HQY) Q4 2026 Earnings Transcript - The Globe and Mail
Earnings call transcript: HealthEquity Q4 2026 beats EPS & revenue forecasts - Investing.com
HQY: Record HSA growth, margin expansion, and raised FY27 guidance highlight strong performance - TradingView
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
HealthEquity (HQY) Surpasses Revenue Expectations and Elevates F - GuruFocus
HQY Projects Strong Financial Performance for FY27 - GuruFocus
Healthequity Inc reports results for the quarter ended January 31Earnings Summary - TradingView
HealthEquity Fiscal Q4 & Annual Results 2026: Earnings Beat ForecastsNews and Statistics - IndexBox
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook - Bitget
HealthEquity: Fiscal Fourth Quarter Earnings Overview - Bitget
HealthEquity: Fiscal Q4 Earnings Snapshot - marketscreener.com
HealthEquity (HQY) Releases Q4 2026 Earnings: Revenue Growth and Margin Improvement but EPS Miss - Quiver Quantitative
HealthEquity Fiscal Q4 Adjusted Earnings, Revenue Rise - marketscreener.com
HealthEquity's Q4 revenue rises, slightly beating estimates - TradingView
HealthEquity beats Q4 estimates, raises FY27 guidance - Investing.com
(HQY) HealthEquity Expects Revenue Range $1.405B-$1.415B for Fiscal Year Ending Jan. 31, 2027, vs. FactSet Est of $1.41B - marketscreener.com
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):